Works matching AU Al‐Kali, Aref

Results: 132
    1

    Clinical Outcome and Molecular Profile in Patients with DDX41 Mutation Hot-Spots.

    Published in:
    Hematology Reports, 2025, v. 17, n. 3, p. 26, doi. 10.3390/hematolrep17030026
    By:
    • Toumeh, Nadia;
    • Jabban, Yazan;
    • Nanaa, Ahmad;
    • He, Rong;
    • Viswanatha, David;
    • Jevremovic, Dragan;
    • Foran, James M.;
    • Arana Yi, Cecilia Y.;
    • Saliba, Antoine N.;
    • Hefazi Torghabeh, Mehrdad;
    • Hogan, William J.;
    • Shah, Mithun V.;
    • Mangaonkar, Abhishek A.;
    • Patnaik, Mrinal M.;
    • Alkhateeb, Hassan B.;
    • Al-Kali, Aref
    Publication type:
    Article
    2
    3
    4
    5
    6
    7

    Multihit TP53 Mutations in Myeloproliferative Neoplasms and Acute Myeloid Leukemia: Comparative Analysis of Survival and Risk Factors in 142 Informative Cases.

    Published in:
    American Journal of Hematology, 2025, v. 100, n. 6, p. 1010, doi. 10.1002/ajh.27670
    By:
    • Fathima, Saubia;
    • Abdelmagid, Maymona;
    • Alsugair, Ali;
    • Begna, Kebede H.;
    • Al‐Kali, Aref;
    • Mangaonkar, Abhishek A.;
    • Pardanani, Animesh D.;
    • Patnaik, Mrinal M.;
    • Zepeda Mendoza, Cinthya J.;
    • He, Rong;
    • Reichard, Kaaren K.;
    • Badar, Talha;
    • Foran, James M.;
    • Palmer, Jeanne;
    • Loscocco, Giuseppe G.;
    • Guglielmelli, Paola;
    • Vannucchi, Alessandro M.;
    • Orazi, Attilio;
    • Arber, Daniel A.;
    • Hiwase, Devendra
    Publication type:
    Article
    8

    TP53 Mutations in Myeloproliferative Neoplasms: Context‐Dependent Evaluation of Prognostic Relevance.

    Published in:
    American Journal of Hematology, 2025, v. 100, n. 4, p. 552, doi. 10.1002/ajh.27609
    By:
    • Tefferi, Ayalew;
    • Abdelmagid, Maymona;
    • Loscocco, Giuseppe G.;
    • Fathima, Saubia;
    • Begna, Kebede H.;
    • Al‐Kali, Aref;
    • Foran, James;
    • Palmer, Jeanne;
    • Badar, Talha;
    • Patnaik, Mrinal M.;
    • Reichard, Kaaren K.;
    • He, Rong;
    • Zepeda Mendoza, Cinthya J.;
    • Shah, Mithun;
    • Orazi, Attilio;
    • Arber, Daniel A.;
    • Pardanani, Animesh;
    • Vannucchi, Alessandro M.;
    • Hiwase, Devendra;
    • Gangat, Naseema
    Publication type:
    Article
    9

    Mayo Genetic Risk Models for Newly Diagnosed Acute Myeloid Leukemia Treated With Venetoclax + Hypomethylating Agent.

    Published in:
    American Journal of Hematology, 2025, v. 100, n. 2, p. 260, doi. 10.1002/ajh.27564
    By:
    • Gangat, Naseema;
    • Elbeih, Azeem;
    • Ghosoun, Nour;
    • McCullough, Kristen;
    • Aperna, Fnu;
    • Johnson, Isla M.;
    • Abdelmagid, Maymona;
    • Al‐Kali, Aref;
    • Alkhateeb, Hassan B.;
    • Begna, Kebede H.;
    • Elliott, Michelle;
    • Mangaonkar, Abhishek;
    • Matin, Aasiya;
    • Saliba, Antoine N.;
    • Hefazi Torghabeh, Mehrdad;
    • Litzow, Mark R.;
    • Hogan, William;
    • Shah, Mithun;
    • Patnaik, Mrinal M.;
    • Pardanani, Animesh
    Publication type:
    Article
    10

    PHF6 mutations in chronic myelomonocytic leukemia identify a unique subset of patients with distinct phenotype and superior prognosis.

    Published in:
    American Journal of Hematology, 2024, v. 99, n. 12, p. 2321, doi. 10.1002/ajh.27492
    By:
    • Tefferi, Ayalew;
    • Fathima, Saubia;
    • Alsugair, Ali Khalid A.;
    • Aperna, Fnu;
    • Natu, Anuya;
    • Abdelmagid, Maymona G.;
    • Csizmar, Clifford M.;
    • Gurney, Mark;
    • Lasho, Terra L.;
    • Finke, Christy M.;
    • Mangaonkar, Abhishek A.;
    • Al‐Kali, Aref;
    • Pardanani, Animesh;
    • Reichard, Kaaren K.;
    • He, Rong;
    • Gangat, Naseema;
    • Patnaik, Mrinal M.
    Publication type:
    Article
    11

    Venetoclax duration (14 vs. 21 vs. 28 days) in combination with hypomethylating agent in newly diagnosed acute myeloid leukemia: Comparative analysis of response, toxicity, and survival.

    Published in:
    American Journal of Hematology, 2024, v. 99, n. 2, p. E63, doi. 10.1002/ajh.27180
    By:
    • Karrar, Omer;
    • Abdelmagid, Maymona;
    • Rana, Masooma;
    • Iftikhar, Moazah;
    • McCullough, Kristen;
    • Al‐Kali, Aref;
    • Alkhateeb, Hassan B.;
    • Begna, Kebede H.;
    • Elliott, Michelle A.;
    • Mangaonkar, Abhishek;
    • Saliba, Antoine;
    • Hefazi Torghabeh, Mehrdad;
    • Litzow, Mark R.;
    • Hogan, William;
    • Shah, Mithun;
    • Patnaik, Mrinal M.;
    • Pardanani, Animesh;
    • Badar, Talha;
    • Murthy, Hemant;
    • Foran, James
    Publication type:
    Article
    12

    Venetoclax and hypomethylating agent combination therapy in newly diagnosed acute myeloid leukemia: Genotype signatures for response and survival among 301 consecutive patients.

    Published in:
    American Journal of Hematology, 2024, v. 99, n. 2, p. 193, doi. 10.1002/ajh.27138
    By:
    • Gangat, Naseema;
    • Karrar, Omer;
    • Iftikhar, Moazah;
    • McCullough, Kristen;
    • Johnson, Isla M.;
    • Abdelmagid, Maymona;
    • Abdallah, Mostafa;
    • Al‐Kali, Aref;
    • Alkhateeb, Hassan B.;
    • Begna, Kebede H.;
    • Mangaonkar, Abhishek;
    • Saliba, Antoine N.;
    • Hefazi Torghabeh, Mehrdad;
    • Litzow, Mark R.;
    • Hogan, William;
    • Shah, Mithun;
    • Patnaik, Mrinal M.;
    • Pardanani, Animesh;
    • Badar, Talha;
    • Murthy, Hemant
    Publication type:
    Article
    13
    14

    Mast cell cytomorphology and treatment outcome in mast cell leukemia.

    Published in:
    American Journal of Hematology, 2024, v. 99, n. 1, p. E5, doi. 10.1002/ajh.27105
    By:
    • Tefferi, Ayalew;
    • Pardanani, Animesh;
    • Al‐Kali, Aref;
    • Alkhateeb, Hassan;
    • McCullough, Kristen;
    • Patnaik, Mrinal;
    • Hogan, William J.;
    • Begna, Kebede;
    • Elliott, Michelle A.;
    • Khera, Nandita;
    • Palmer, Jeanne M.;
    • Gangat, Naseema;
    • Kelemen, Katalin;
    • Orazi, Attilio;
    • Chen, Dong;
    • Reichard, Kaaren K.
    Publication type:
    Article
    15
    16
    17
    18

    TP53 mutations and variant allele frequency in myelodysplastic syndromes with del(5q): A Mayo‐Moffitt study of 156 informative cases.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 4, p. E76, doi. 10.1002/ajh.26845
    By:
    • Fleti, Farah;
    • Chan, Onyee;
    • Singh, Amritpal;
    • Abdelmagid, Maymona G.;
    • Al‐Kali, Aref;
    • Elliott, Michelle A.;
    • Begna, Kebede H.;
    • Foran, James M.;
    • Badar, Talha;
    • Khera, Nandita;
    • Al Ali, Najla H.;
    • Padron, Eric;
    • Sallman, David A.;
    • Shah, Mithun;
    • Hiwase, Devendra;
    • Pardanani, Animesh;
    • Arber, Daniel A.;
    • Orazi, Attilio;
    • Reichard, Kaaren K.;
    • He, Rong
    Publication type:
    Article
    19
    20
    21
    22
    23

    Lenalidomide therapy for primary myelodysplastic syndromes with isolated del(5q): Determinants of response and survival in a real‐world setting.

    Published in:
    American Journal of Hematology, 2022, v. 97, n. 10, p. E377, doi. 10.1002/ajh.26672
    By:
    • Singh, Amritpal;
    • Al‐Kali, Aref;
    • Foran, James M.;
    • Elliott, Michelle A.;
    • Begna, Kebede;
    • Badar, Talha;
    • Khera, Nandita;
    • Fleti, Farah;
    • Abdelmagid, Maymona;
    • Reichard, Kareen K.;
    • Ketterling, Rhett P.;
    • Pardanani, Animesh;
    • Gangat, Naseema;
    • Tefferi, Ayalew
    Publication type:
    Article
    24

    A dynamic 3‐factor survival model for acute myeloid leukemia that accounts for response to induction chemotherapy.

    Published in:
    American Journal of Hematology, 2022, v. 97, n. 9, p. 1127, doi. 10.1002/ajh.26630
    By:
    • Tefferi, Ayalew;
    • Gangat, Naseema;
    • Al‐Kali, Aref;
    • Alkhateeb, Hassan;
    • Shah, Mithun;
    • Patnaik, Mrinal S.;
    • Elliott, Michelle A.;
    • Hogan, William J.;
    • Litzow, Mark R.;
    • Hook, Christopher C.;
    • Mangaonkar, Abhishek;
    • Viswanatha, David;
    • Chen, Dong;
    • Pardanani, Animesh;
    • Ketterling, Rhett P.;
    • DiNardo, Courtney D.;
    • Kadia, Tapan M.;
    • Ravandi, Farhad;
    • Sasaki, Koji;
    • Begna, Kebede H.
    Publication type:
    Article
    25

    Outcomes following venetoclax‐based treatment in therapy‐related myeloid neoplasms.

    Published in:
    American Journal of Hematology, 2022, v. 97, n. 8, p. 1013, doi. 10.1002/ajh.26589
    By:
    • Shah, Mithun Vinod;
    • Chhetri, Rakchha;
    • Dholakia, Ruchita;
    • Kok, Chung H.;
    • Gangat, Naseema;
    • Alkhateeb, Hassan B.;
    • Al‐Kali, Aref;
    • Patnaik, Mrinal M.;
    • Baranwal, Anmol;
    • Greipp, Patricia T.;
    • He, Rong;
    • Begna, Kebede H.;
    • Tiong, Ing Soo;
    • Wei, Andrew H.;
    • Hiwase, Devendra
    Publication type:
    Article
    26

    Real‐world experience with venetoclax and hypomethylating agents in myelodysplastic syndromes with excess blasts.

    Published in:
    American Journal of Hematology, 2022, v. 97, n. 6, p. E214, doi. 10.1002/ajh.26539
    By:
    • Gangat, Naseema;
    • McCullough, Kristen;
    • Johnson, Isla;
    • Al‐Kali, Aref;
    • Begna, Kebede H.;
    • Patnaik, Mrinal M.;
    • Litzow, Mark R.;
    • Hogan, William;
    • Shah, Mithun;
    • Alkhateeb, Hassan;
    • Mangaonkar, Abhishek;
    • Foran, James M.;
    • Badar, Talha;
    • Palmer, Jeanne M.;
    • Sproat, Lisa;
    • Arana Yi, Cecilia Y.;
    • Pardanani, Animesh;
    • Tefferi, Ayalew
    Publication type:
    Article
    27
    28
    29
    30

    Gilteritinib clinical activity in relapsed/refractory FLT3 mutated acute myeloid leukemia previously treated with FLT3 inhibitors.

    Published in:
    American Journal of Hematology, 2022, v. 97, n. 3, p. 322, doi. 10.1002/ajh.26447
    By:
    • Numan, Yazan;
    • Abdel Rahman, Zaid;
    • Grenet, Justin;
    • Boisclair, Stephanie;
    • Bewersdorf, Jan Philipp;
    • Collins, Cailin;
    • Barth, Dylan;
    • Fraga, Martina;
    • Bixby, Dale L.;
    • Zeidan, Amer M.;
    • Yilmaz, Musa;
    • Desai, Pankil;
    • Mannis, Gabriel;
    • Deutsch, Yehuda E.;
    • Abaza, Yasmin;
    • Dinner, Shira;
    • Frankfurt, Olga;
    • Litzow, Mark;
    • Al‐Kali, Aref;
    • Foran, James M.
    Publication type:
    Article
    31
    32
    33

    Spectrum of hematological malignancies, clonal evolution and outcomes in 144 Mayo Clinic patients with germline predisposition syndromes.

    Published in:
    American Journal of Hematology, 2021, v. 96, n. 11, p. 1450, doi. 10.1002/ajh.26321
    By:
    • Martin, Emma St;
    • Ferrer, Alejandro;
    • Mangaonkar, Abhishek A.;
    • Khan, Shakila P.;
    • Kohorst, Mira A.;
    • Joshi, Avni Y.;
    • Hogan, William J.;
    • Olteanu, Horatiu;
    • Moyer, Ann M.;
    • Al‐Kali, Aref;
    • Tefferi, Ayalew;
    • Chen, Dong;
    • Wudhikarn, Kitsada;
    • Go, Ronald;
    • Viswanatha, David;
    • He, Rong;
    • Ketterling, Rhett;
    • Nguyen, Phuong L.;
    • Oliveira, Jennifer L.;
    • Gangat, Naseema
    Publication type:
    Article
    34

    Venetoclax with azacitidine or decitabine in blast‐phase myeloproliferative neoplasm: A multicenter series of 32 consecutive cases.

    Published in:
    American Journal of Hematology, 2021, v. 96, n. 7, p. 781, doi. 10.1002/ajh.26186
    By:
    • Gangat, Naseema;
    • Guglielmelli, Paola;
    • Szuber, Natasha;
    • Begna, Kebede H.;
    • Patnaik, Mrinal M.;
    • Litzow, Mark R.;
    • Al‐Kali, Aref;
    • Foran, James M.;
    • Palmer, Jeanne M.;
    • Alkhateeb, Hassan;
    • Elliott, Michelle A.;
    • Hanson, Curtis A.;
    • Pardanani, Animesh;
    • Mannelli, Francesco;
    • Vannucchi, Alessandro M.;
    • Tefferi, Ayalew
    Publication type:
    Article
    35

    Acute myeloid leukemia after age 70 years: A retrospective comparison of survival following treatment with intensive versus HMA ± venetoclax chemotherapy.

    Published in:
    American Journal of Hematology, 2021, v. 96, n. 4, p. E108, doi. 10.1002/ajh.26112
    By:
    • Begna, Kebede H.;
    • Gangat, Naseema;
    • Al‐Kali, Aref;
    • Litzow, Mark R.;
    • Hogan, William J.;
    • Patnaik, Mrinal M.;
    • Pardanani, Animesh;
    • Hook, C. Christopher;
    • Wolanskyj, Alexandra P.;
    • Elliott, Michelle A.;
    • Hanson, Curtis A.;
    • Ketterling, Rhett P.;
    • Tefferi, Ayalew
    Publication type:
    Article
    36
    37
    38
    39

    Clinical utility of fluorescence in situ hybridization‐based diagnosis of BCR‐ABL1 like (Philadelphia chromosome like) B‐acute lymphoblastic leukemia.

    Published in:
    American Journal of Hematology, 2020, v. 95, n. 3, p. E68, doi. 10.1002/ajh.25729
    By:
    • Anagnostou, Theodora;
    • Knudson, Ryan A.;
    • Pearce, Kathryn E.;
    • Meyer, Reid G.;
    • Pitel, Beth A.;
    • Peterson, Jess F.;
    • Baughn, Linda B.;
    • Reichard, Kaaren K.;
    • Ketterling, Rhett P.;
    • Kloft‐Nelson, Sara M.;
    • Knutson, Darlene L.;
    • Khan, Shakila P.;
    • Gangat, Naseema;
    • Litzow, Mark R.;
    • Hogan, William J.;
    • Wolanskyj, Alexandra;
    • Al‐Kali, Aref;
    • Begna, Kebede H.;
    • Elliott, Michelle;
    • Pardanani, Animesh
    Publication type:
    Article
    40

    Suboptimal response rates to hypomethylating agent therapy in chronic myelomonocytic leukemia; a single institutional study of 121 patients.

    Published in:
    American Journal of Hematology, 2019, v. 94, n. 7, p. 767, doi. 10.1002/ajh.25488
    By:
    • Coston, Tucker;
    • Pophali, Prateek;
    • Vallapureddy, Rangit;
    • Lasho, Terra L.;
    • Finke, Christy M.;
    • Ketterling, Rhett P.;
    • Carr, Ryan;
    • Binder, Moritz;
    • Mangaonkar, Abhishek A.;
    • Gangat, Naseema;
    • Al‐Kali, Aref;
    • Litzow, Mark;
    • Zblewski, Darci;
    • Pardanani, Animesh;
    • Tefferi, Ayalew;
    • Patnaik, Mrinal M.
    Publication type:
    Article
    41

    A novel predictive model of outcome in acute myeloid leukemia without favorable karyotype based on treatment strategy, karyotype and FLT3‐ITD mutational status.

    Published in:
    American Journal of Hematology, 2018, v. 93, n. 12, p. E401, doi. 10.1002/ajh.25290
    By:
    • Begna, Kebede H.;
    • Ali, Walid;
    • Gangat, Naseema;
    • Elliott, Michelle A.;
    • Al‐Kali, Aref;
    • Litzow, Mark R.;
    • Hook, C. Christopher;
    • Wolanskyj, Alexandra P.;
    • Hogan, William J.;
    • Patnaik, Mrinal M.;
    • Pardanani, Animesh;
    • Zblewski, Darci L.;
    • Chen, Dong;
    • He, Rong;
    • Viswanatha, David;
    • Hanson, Curtis A.;
    • Ketterling, Rhett P.;
    • Tefferi, Ayalew
    Publication type:
    Article
    42
    43
    44

    Pre‐anthracycline echocardiogram rarely changes treatment strategy in acute myeloid leukemia.

    Published in:
    American Journal of Hematology, 2018, v. 93, n. 6, p. E144, doi. 10.1002/ajh.25083
    By:
    • Ogden, John;
    • Yui, Jennifer;
    • Ali, Walid;
    • Mudireddy, Mythri;
    • Al‐Kali, Aref;
    • Patnaik, Mrinal;
    • Gangat, Naseema;
    • Elliott, Michelle;
    • Hogan, William;
    • Hook, Christopher;
    • Wolanskyj‐Spinner, Alexandra;
    • Pardanani, Animesh;
    • Villarraga, Hector;
    • Litzow, Mark;
    • Tefferi, Ayalew;
    • Begna, Kebede
    Publication type:
    Article
    45
    46

    Current treatment preferences in chronic myeloid leukemia: The Mayo Clinic Physicians' survey.

    Published in:
    American Journal of Hematology, 2017, v. 92, n. 11, p. E626, doi. 10.1002/ajh.24866
    By:
    • Begna, Kebede;
    • Al-Kali, Aref;
    • Elliott, Michelle;
    • Foran, James;
    • Gangat, Naseema;
    • Hogan, William;
    • Hook, Christopher;
    • Leis, Jose;
    • Litzow, Mark;
    • Mesa, Ruben;
    • Palmer, Jeanne;
    • Pardanani, Animesh;
    • Patnaik, Mrinal;
    • Rivera, Candido;
    • Sproat, Lisa;
    • Tibes, Raoul;
    • Wolanskyj-Spinner, Alexandra;
    • Tefferi, Ayalew
    Publication type:
    Article
    47
    48

    Prognostic impact of RAS mutations in patients with myelodysplastic syndrome.

    Published in:
    American Journal of Hematology, 2013, v. 88, n. 5, p. 365, doi. 10.1002/ajh.23410
    By:
    • Al-Kali, Aref;
    • Quintás-Cardama, Alfonso;
    • Luthra, Raja;
    • Bueso-Ramos, Carlos;
    • Pierce, Sherry;
    • Kadia, Tapan;
    • Borthakur, Gautam;
    • Estrov, Zeev;
    • Jabbour, Elias;
    • Faderl, Stefan;
    • Ravandi, Farhad;
    • Cortes, Jorges;
    • Tefferi, Ayalew;
    • Kantarjian, Hagop;
    • Garcia-Manero, Guillermo
    Publication type:
    Article
    49
    50